Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.84% is 40% below its 5-year average of 9.75%, near the low end of its 5-year range (5.74%–29.24%).
As of the fiscal period ended Tuesday, June 30, 2026. 30.51% below its 12-month average of 8.40%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.84%.
DEBT TO ASSETS RATIO
5.84%
DEBT TO ASSETS RATIO AVG TTM
8.40%
DEBT TO ASSETS RATIO AVG 3Y
8.25%
DEBT TO ASSETS RATIO AVG 5Y
9.75%
DEBT TO ASSETS RATIO AVG 10Y
11.28%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-30.51%
CURRENT VS 3Y AVG
-29.27%
CURRENT VS 5Y AVG
-40.11%
CURRENT VS 10Y AVG
-48.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+1948.45%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$17.32B
Debt to Assets Ratio
5.84%
TTM Avg
8.40%
3Y Avg
8.25%
5Y Avg
9.75%
Market Cap
$19.04B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.60B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.24B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.14B
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.32B | 5.84% | 8.40% | 8.25% | 9.75% |
| Revvity, Inc. (RVTY)vs › | $15.64B | 0.28% | N/A | N/A | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $19.04B | 0.33% | N/A | N/A | N/A |
| Solventum Corporation (SOLV)vs › | $15.60B | 0.37% | N/A | N/A | N/A |
| Viatris Inc. (VTRS)vs › | $19.39B | 0.39% | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.30B | 0.07% | N/A | N/A | N/A |
| STERIS plc (STE)vs › | $20.49B | 0.19% | N/A | N/A | N/A |
| United Therapeutics Corporation (UTHR)vs › | $21.24B | 0.00% | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.14B | 0.40% | N/A | N/A | N/A |
| Penumbra, Inc. (PEN)vs › | $12.54B | 0.11% | N/A | N/A | N/A |
Debt/Assets
5.8%
Debt/Equity
0.28
Current Ratio
0.73
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.84% |
| 2026-03-31 | 5.74% |
| 2025-12-31 | 12.68% |
| 2025-09-30 | 8.21% |
| 2025-06-30 | 9.53% |
| 2025-03-31 | 6.68% |
| 2024-12-31 | 6.01% |
| 2024-09-30 | 6.16% |
| 2024-06-30 | 6.86% |
| 2024-03-31 | 7.58% |
| 2023-12-31 | 8.58% |
| 2023-09-30 | 9.62% |
| 2023-06-30 | 13.82% |
| 2023-03-31 | 18.46% |
| 2022-12-31 | 13.96% |
| 2022-09-30 | 21.00% |
| 2022-06-30 | 29.24% |
| 2022-03-31 | 10.53% |
| 2021-12-31 | 7.89% |
| 2021-09-30 | 8.13% |
| 2021-06-30 | 7.68% |
| 2021-03-31 | 7.86% |
| 2020-12-31 | 8.28% |
| 2020-09-30 | 8.54% |
| 2020-06-30 | 9.41% |
| 2020-03-31 | 4.52% |
| 2019-12-31 | 3.96% |
| 2019-09-30 | 4.29% |
| 2019-06-30 | 4.30% |
| 2019-03-31 | 10.14% |
| 2018-12-31 | 8.24% |
| 2018-09-30 | 11.97% |
| 2018-06-30 | 16.89% |
| 2018-03-31 | 20.30% |
| 2017-12-31 | 23.31% |
| 2017-09-30 | 19.46% |
| 2017-06-30 | 16.36% |
| 2017-03-31 | 16.63% |
| 2016-12-31 | 16.71% |
| 2016-09-30 | 15.83% |
| 2016-06-30 | 36.59% |
| 2016-03-31 | 38.07% |
| 2015-12-31 | 38.41% |
